MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC ROA 2011-2026 | OXFD
ROA Jährlich Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | -0.77 | 52.03 | -22.8 | -18.02 | -22.28 | -30.03 | -9.34 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 52.03 | -30.03 | -7.32 |
ROA anderer Aktien in der Diagnostik & Forschung
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Biodesix
BDSX
|
-44.15 | $ 15.54 | 5.79 % | $ 2.02 B |  USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.16 | 1.41 % | $ 4.96 M | USA |
 |
Bioventus
BVS
|
3.33 | $ 9.15 | 1.67 % | $ 610 M | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 16.34 | 0.06 % | $ 494 M | USA |
 |
Guardant Health
GH
|
-20.67 | $ 83.59 | -1.54 % | $ 10.5 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 101.28 | 0.93 % | $ 8.35 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
31.62 | $ 570.21 | -1.43 % | $ 45.9 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 74.24 | -1.97 % | $ 5.01 B | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 460.74 | 0.83 % | $ 13.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 264.46 | 1.94 % | $ 26.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.61 | -1.07 % | $ 427 M | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 17.44 | -0.4 % | $ 390 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Natera
NTRA
|
-39.28 | $ 194.52 | -2.78 % | $ 19.1 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 159.19 | 0.75 % | $ 7.89 B | USA |
 |
IQVIA Holdings
IQV
|
4.54 | $ 166.09 | -0.52 % | $ 28.6 B | USA |
 |
Organovo Holdings
ONVO
|
-16.98 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.39 | - | $ 417 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.18 | -19.18 % | $ 6.43 M | USA |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 125.98 | 1.77 % | $ 20 B | USA |
 |
Personalis
PSNL
|
-30.08 | $ 7.78 | 2.23 % | $ 461 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
-32.34 | $ 26.6 | -1.23 % | $ 34.5 M | USA |
 |
RadNet
RDNT
|
-0.5 | $ 59.87 | -3.03 % | $ 4.5 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 102.01 | -4.44 % | $ 4.02 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 266.12 | 0.64 % | $ 22.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 3.46 | -0.57 % | $ 1.86 M | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 7.86 | -2.96 % | $ 1.01 B | USA |
 |
Renalytix AI plc
RNLX
|
-419.67 | - | 5.66 % | $ 22.7 M |  Britain |